BreitSHublD.2025. The effects of GLP-1ARs on mental health and psychotropics-induced metabolic disorders: a systematic review. Psychoneuroendocrinology176:107415.
2.
ChaoAMTronieriJSAmaroAWaddenTA. (2023). Semaglutide for the treatment of obesity. Trends Cardiovasc Med33:159–66.
3.
FriedmanJM. (2024). The discovery and development of GLP-1 based drugs that have revolutionized the treatment of obesity. Proc Natl Acad Sci U S A121:e2415550121.
4.
HayashiDEdwardsCEmondJAGilbert-DiamondDButtMRigbyAMastersonTD. 2023. What is food noise? A conceptual model of food cue reactivity. Nutrients15:4809.
5.
MeshkatSDi LucianoCSwiderskiALiGAguilarRJDunkleyBT and others. (2025). Efficacy and safety of glucagon-like peptide agonists for psychiatric symptoms: a systematic review. Brain Behav15:e70661.
